That is because Alvotech and commercial partner Teva have claimed approval for their Simlandi biosimilar of Humira (adalimumab), which includes the first and so far only fully interchangeable ...

A U.S. unit of generic drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) and Luxembourg-based Alvotech (NASDAQ:ALVO) have launched Simlandi, an interchangeable biosimilar version, targeting ...

Alvotech (NASDAQ:ALVO) and partner Teva Pharmaceuticals (NYSE:TEVA) announced Friday the U.S. Food and Drug Administration (FDA) approval for their arthritis injection, Simlandi (adalimumab-ryvk).

The success of AVT05 builds on recent approvals of other biosimilars, such as SIMLANDI and SELARSDI. ALVO closed Friday's (Jan.24, 2025) trading at $12.99 down 0.99%. TEVA closed Friday's (Jan.24 ...